The presentation format for each abstract will be determined by the Scientific Program Committee. The types of presentations include the following:
Oral Abstract Sessions
This type of session includes several 15-minute presentations of abstracts representing important clinical and translational research findings by topic category. Presenting authors may use PowerPoint slides to accompany their oral presentation. Experts in the field (Discussants) are chosen to provide comprehensive 15-minute themed discussions of the findings from predetermined abstracts. The duration of this type of session is 3 hours. A limited number of abstracts deemed to represent the best science will be selected for presentation in the noncompeting Plenary Session.
Clinical Science Symposia
These sessions incorporate the presentation of meritorious abstracts with a didactic lecture by an expert who summarizes the field and places the abstracts in the appropriate context, with a focus on how the findings apply to clinical practice. Abstracts selected for these high-profile sessions may cross disease sites or disciplines but are unified in their focus on a key scientific topic as it relates to the field of cancer research.
There are two types of Poster Sessions: General Poster Sessions and Poster Discussion Sessions.
Poster Discussion Sessions: Smaller than General Poster Sessions, these sessions feature posters grouped by topic or by questions posed as a result of research findings. First Authors should be available at posters for a minimum of 2 hours during the display period to answer questions. Following the poster display period, experts in the field (Discussants) are chosen to provide themed discussions placing the abstracts in the appropriate context, with a focus on how the findings apply to clinical practice.
General Poster Sessions: Selected abstracts are grouped by topic and displayed on poster boards for 4 hours. The ASCO Annual Meeting will again include Trials in Progress abstracts within each track, designed to facilitate awareness of open, ongoing clinical trials of any phase. First Authors should be available at their poster for a minimum of 2 hours to informally answer questions from Meeting attendees.
First Authors of abstracts selected for either type of Poster Session will be invited to submit a PowerPoint presentation of their posters in advance of the Annual Meeting to be posted on the Virtual Meeting and included in the ePoster display.